Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-small-cell lung cancer patients: a retrospective multicenter study
暂无分享,去创建一个
T. Morimoto | K. Nagata | J. Uchida | Hidekazu Suzuki | K. Hirano | T. Ishida | T. Hirashima | T. Yokoyama | M. Tamiya | A. Tamiya | T. Kumagai | M. Mori | D. Fujimoto | Ikue Fukuda | Satoshi Tanaka | K. Tomii | Y. Taniguchi | M. Kanazu | M. Morita | K. Hosoya | H. Matsumoto | Ryota Kominami